Nanox Vision

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and novel digital source. Nanox’s vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically-driven approach. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; Nanox.AI – an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE, a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc. that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance its better health outcomes worldwide.

Nanox Vision has raised $330M in total funding across 6 rounds. The company is currently at the Public stage. Key investors include The Yozma Group, SK Ventures, Fujifilm.

Nanox Vision operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Decision Support, with core technologies in Platforms & Interfaces, Software, Data Storage, Cloud, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Medical Equipment, Healthcare, Patients, Providers.

Nanox Vision is based in Petah Tikva, Israel, Center District. The company also has offices abroad.